Ascom secures substantial healthcare contract in the US 

Jun 17, 2020

A prominent American healthcare provider based in the Midwest has selected Ascom to integrate the Ascom Healthcare Platform. The contract value amounts to CHF 1.2 million.

Ascom is already a proven and trusted provider for this Integrated Delivery Network (IDN). The Ascom Healthcare Platform includes Ascom Myco 3 smartphones, the Ascom Unite integration platform, nurse call integration, and customized project management, workflow design and clinical training.

Ascom will roll out its solutions to every facility and campus of this IDN, where it will provide integration and clinical mobility capabilities that deliver smoother, more efficient workflows and timelier, targeted clinical communications.

Kelly Feist, Managing Director of Ascom USA & Canada, says: “We are very pleased to further strengthen this important long-term customer relationship by moving forward with their next phase of implementation. For all of our healthcare clients, Ascom works to contribute to more affordable and sustainable healthcare for patients and frontline staff.”


This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).